48 related articles for article (PubMed ID: 16201530)
1. PET and SPECT in common neuropsychiatric disease.
Tatsch K; Ell PJ
Clin Med (Lond); 2006; 6(3):259-62. PubMed ID: 16826858
[No Abstract] [Full Text] [Related]
2. Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis.
Siepmann DB; Siegel A; Lewis PJ
Clin Nucl Med; 2005 Mar; 30(3):199-200. PubMed ID: 15722830
[No Abstract] [Full Text] [Related]
3. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
[TBL] [Abstract][Full Text] [Related]
4. Determination of brain tumor recurrence using
Yamaguchi S; Hirata K; Okamoto M; Shimosegawa E; Hatazawa J; Hirayama R; Kagawa N; Kishima H; Oriuchi N; Fujii M; Kobayashi K; Kobayashi H; Terasaka S; Nishijima KI; Kuge Y; Ito YM; Nishihara H; Tamaki N; Shiga T
Cancer Sci; 2021 Oct; 112(10):4246-4256. PubMed ID: 34061417
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
6. The value of
Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
[TBL] [Abstract][Full Text] [Related]
7. [Clinical application of positron emission tomography and 18FDG to brain tumor].
Momose T
Nihon Rinsho; 2005 Sep; 63 Suppl 9():242-9. PubMed ID: 16201530
[No Abstract] [Full Text] [Related]
8. [11C-methionine positron emission tomography in brain tumor].
Kawai N; Kagawa M; Hatakeyama T; Tamiya T; Noshiyama Y; Yamamoto Y; Miki A; Ichikawa T
No Shinkei Geka; 2008 Oct; 36(10):847-59. PubMed ID: 18975560
[No Abstract] [Full Text] [Related]
9. Glioblastoma multiforme imaging: the role of nuclear medicine.
Alexiou GA; Tsiouris S; Voulgaris S; Kyritsis AP; Fotopoulos AD
Curr Radiopharm; 2012 Oct; 5(4):308-13. PubMed ID: 22642425
[TBL] [Abstract][Full Text] [Related]
10. PET imaging for differentiating recurrent brain tumor from radiation necrosis.
Hustinx R; Pourdehnad M; Kaschten B; Alavi A
Radiol Clin North Am; 2005 Jan; 43(1):35-47. PubMed ID: 15693646
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
12. Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
Strauss SB; Meng A; Ebani EJ; Chiang GC
Neuroimaging Clin N Am; 2021 Feb; 31(1):103-120. PubMed ID: 33220823
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]